SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 147 | 180 | +33 |
| Shares | 68.5M | 75.4M | +6.90M (+10.1%) |
| Value | $1.58B | $2.75B | +$1.17B (+74.1%) |
New holders (53)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (20)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| EcoR1 Capital, LLC | 3,460,208 | $80.0M |
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71.2M |
| Baker Bros. Advisors LP | 2,999,846 | $69.4M |
| Ikarian Capital, LLC | 178,360 | $4.12M |
| Iron Triangle Partners LP | 150,211 | $3.47M |
| Walleye Capital LLC | 144,307 | $3.34M |
| Twinbeech Capital LP | 122,429 | $2.83M |
| Balyasny Asset Management LLC | 47,218 | $1.09M |
| Boothbay Fund Management, LLC | 38,447 | $888.9K |
| Squarepoint Ops LLC | 33,768 | $780.7K |
| Financial Security Advisor, Inc. | 31,758 | $734.2K |
| Engineers Gate Manager LP | 28,178 | $651.5K |
| ExodusPoint Capital Management, LP | 27,022 | $625.0K |
| Two Sigma Advisers, LP | 12,400 | $286.7K |
| Walleye Trading LLC | 8,242 | $190.6K |
| Quadrant Capital Group LLC | 52 | $1.20K |
| Park Place Capital Corp | 24 | $555 |
| Glassman Wealth Services | 12 | $277 |
| Harbour Investments, Inc. | 10 | $231 |
| Larson Financial Group LLC | 9 | $208 |